a Background: Central arterial pressure is a better predictor of adverse cardiovascular outcomes than brachial blood pressure, but noninvasive measurement by applanation tonometry is technically demanding.
INTRODUCTION
T here is increasing evidence that central arterial pressure predicts cardiovascular outcomes more reliably than peripherally measured brachial pressures [1] [2] [3] [4] . Brachial blood pressures do not accurately reflect central blood pressures as a result of peripheral amplification, and there is a considerable variation in central blood pressure even between individuals with similar brachial blood pressure [5, 6] . Cardiovascular outcomes also differ between different classes of antihypertensive medication despite similar reductions in peripheral blood pressure. These differences may be explained by different effects on central arterial pressure [7] [8] [9] [10] . Central pressures are pathophysiologically more relevant because they more directly determine cardiac loading and myocardial perfusion, [11, 12] and the arterial pressure waveform conveys useful information regarding systemic vascular compliance [13] . Knowledge of the central arterial characteristics may, therefore, provide an advance in monitoring and titration of interventions in various cardiovascular diseases.
A simple noninvasive method to estimate central aortic pressure wave is needed for research and general clinical application. To date, the most widely used method is applanation tonometry, which uses an externally applied micromanometer-tipped probe to record peripheral pulse waveforms [14, 15] . A generalized transfer function is then applied to correct for pressure wave amplification in the upper limb [16, 17] . However, this method has limitations. Although estimated central SBPs correlate with invasive central measurements [18, 19] , the generalized nature of the transfer function assumes that the properties of the upper limb arteries are identical among all the individuals [20] . In addition, applanation tonometry is technically demanding and, therefore, only suited to research settings with measurements made by trained technicians.
Pulsecor is a novel device which estimates central pressures in the ascending aorta from an oscillometric pressure cuff on the upper arm. A physics-based model is applied to
Description of Pulsecor device
Pulsecor R6.5 (Pulsecor Ltd, Auckland, New Zealand) estimates the central pressures from the brachial cuff pressure fluctuations. First, the device uses oscillometry to determine brachial systolic and diastolic pressures during deflation of the cuff. The device then inflates again and holds cuff pressure approximately 30 mmHg above the brachial systolic pressure (i.e. suprasystolic measurement) for approximately 10 s. Intra-arterial pressure waves impinging on artery occlusion, caused by the suprasystolic cuff, transfer part of their energy to the surrounding upper arm tissue and then into the cuff. The small cuff pressure fluctuations recorded during this period can then be directly related to the intra-arterial pressure oscillations. The intra-arterial pressures in the brachial artery at the cuff measurement site are then used to estimate the pressures in the aorta by applying a physics-based model of the left subclavian-tobrachial branch. The model involves establishing a timedomain representation of pressure wave reflection within a uniform closed tube. Pressure waves enter this tube from the aorta and are transmitted towards the cuff occlusion, where they are reflected back towards the aorta and further reflected within the tube. Total pressure at the aorta and under the cuff are modelled as the superposition of the reflected waves. By estimating the reflection characteristics at the ends of the tube and transmission time for pressure wave propagation down the tube, the model allows estimation of the pressure waveform at the open end of the tube (i.e. the aorta) from the closed end (i.e. under the cuff) [21] .
METHODS

Study population
The study was conducted at the Cardiac Investigations Unit, Auckland City Hospital between January 2010 and December 2010, and was approved by the regional research ethics committee. Eligible patients were identified from those scheduled to undergo diagnostic coronary angiography. Written informed consent was given by all individuals. Patients were excluded if aged less than 30 or more than 80 years, had atrial fibrillation or atrial flutter on ECG, aortic stenosis or aortic regurgitation of any severity, mitral stenosis or mitral regurgitation graded more than mild in severity, severe pulmonary hypertension, ventricular septal defect or other significant intracardiac shunt, aortic coarctation, ventricular pacemaker, haemodynamic instability, active ischaemic symptoms, use of intravenous vasoactive or inotropic medications, history of coronary artery bypass surgery, history of aortic valve replacement, history of thoracic or abdominal aortic surgery and history of left mastectomy with axillary node dissection.
Study protocol
The study involved the acquisition of invasive arterial waveforms and pressures directly measured from the ascending aorta (at the sinotubular junction) or aortic arch (at the left subclavian bifurcation) by Judkins Right catheter or pigtail catheter in patients undergoing diagnostic left heart catheterization, and noninvasive central pressure estimates were obtained simultaneously by Pulsecor R6.5 device.
Invasive calibration involves using invasively measured central mean arterial pressure and central DBP cDBP to calibrate suprasystolic brachial waveform to estimate central SBP (cSBP). This methodology has been recommended to remove the confounding influence of the less accurate brachial oscillometric recordings. Noninvasive calibration involves using oscillometric SBP, DBP, MAP and the normalized suprasystolic brachial waveform obtained by Pulsecor to calibrate the suprasystolic brachial waveform using a method that is specific to the proprietary oscillometric algorithm used in the device. This calibrated waveform is then used to estimate the central pressure waveform, including cSBP and cDBP.
Noninvasive central pressure estimates
Once in the catheter laboratory, the participant's left arm was placed on an arm board with the cuff of the Pulsecor R6.5 device wrapped around the left upper arm. The Pulsecor R6.5 device first inflated and deflated to identify oscillometric brachial SBP and DBP and then inflated again to 30 mmHg above oscillometric brachial systolic pressure for 10 s during which the suprasystolic signals were recorded. During this period of suprasystolic inflation, 10 s of invasive arterial waveforms were simultaneously recorded from the catheter with an ECG to facilitate timing of pulse waveforms.
Invasive central pressure measurements
Participants were prepared according to standard cardiac catheterization laboratory protocols, including administration of sedatives, intravenous fluids and oxygen, as required. Either a femoral or radial arterial access was used to introduce a 6 F Judkins Right 4 or pigtail catheter under local anaesthesia employing the Seldinger technique. Invasive measurements were collected either towards the start or end of the diagnostic coronary investigation, or both. The catheters were 100 cm long (110 cm for pigtail catheter) with an internal diameter of 1.8 mm. The catheters were connected by semirigid fluid-filled tubing to a disposable pressure transducer (TruWave; Edwards Lifesciences, Saint-Prex, Switzerland). At each fluoroscopically confirmed position in the vascular tree, the catheter was attached to a pressure line and 10 s were allowed for the trace to stabilize. Catheter position was adjusted to avoid damping. Transducers were factory calibrated and exceeded Association for the Advancement of Medical Instrumentation (AAMI) standards for performance interchangeability. Calibration of the transducer was verified using the True-Cal system to be within 1 mmHg of the calibrated noninvasive pressure sensor before each study. The transducers were of a precision, solid-state type and with a natural frequency of 40 Hz. The transducers have a sensitivity of 5 mV/V per mmHg AE1%, a nonlinearity of the greater of AE1.5% or AE1 mmHg, and the natural frequency of the system was 40 Hz.
Data processing and analysis
Noninvasive suprasystolic waveforms obtained by Pulsecor R6.5 were digitalized at 200 Hz, and simultaneously, invasive arterial pressure waveforms and ECG were digitalized at 600 Hz and stored for subsequent offline analysis. Invasive data were processed as follows: for the period of the measurement identified from the cuff pressure data, the signal was low-pass filtered with a zero-phase filter and corner frequency of 25 Hz. Each heartbeat was then identified using the recorded ECG R-waves and corresponding segments of the invasive arterial pressure waveform were used to calculate beat by beat systolic, diastolic and mean pressures. Fifth, 50th and 95th percentile systolic, diastolic and mean pressures of the beat ensemble during the noninvasive measurement were calculated. To construct an ensemble-averaged estimation of the invasive pressure waveform, heart beat segments corresponding to the suprasystolic period were median averaged at each sample. Noninvasive data was processed using Pulsecor algorithm MR1522, which implements the model previously described. The output of the model is an estimate of central pressure waveforms over the suprasystolic period, from which an ensemble-averaged pressure waveform was calculated.
Statistical analysis
The agreement between invasive and noninvasive ensemble-average pressures was expressed in terms of mean bias and limits of agreement, as recommended by Bland and Altman [22] . The catheter measurements are considered to provide the closest value to the 'true' arterial readings and are, therefore, plotted on the abscissa. For the data set by both invasive and noninvasive calibration method, the estimated average systolic pressures were compared with the invasively measured median central systolic pressures. In addition, the estimated central pressures by noninvasive calibration method were also compared to the fifth to 95th percentile range of the corresponding invasively measured central pressures over the same period of measurement as recommended by AAMI SP10 criteria. This results in a proportion of points lying along the horizontal axis, indicating that the estimated central pressure was within the fifth and 95th percentiles of invasively measured central pressures recorded during the period of the noninvasive measurement.
Linear regression correlation coefficients between the median invasive and noninvasive central systolic pressures were performed for both calibration methods and paired Srudent's t-test was used for the evaluation of differences between the mean invasive and noninvasive central systolic pressures. P-values less than 0.05 were considered statistically significant. Coefficient of variation was also calculated for both calibration methods to assess dispersion relative to the corresponding invasive measured central systolic pressure values.
RESULTS
The study population was 37 individuals (mean age 64 AE 12 years, range 32-78 years, 12 women, 25 men) undergoing diagnostic coronary angiography via either a femoral (n ¼ 13) or radial (n ¼ 24) approach. Ninety-four simultaneous invasive and noninvasive central aortic pressure readings were obtained. Table 1 provides a summary of clinical characteristics of the patients. Figure 1 demonstrates typical features of synthesized aortic pressure waveform by Pulsecor R6.5 device and simultaneously measured invasive aortic pressure waveform in four example patients at steady state. Synthesized aortic pressure waveforms display good concordance to those directly recorded by invasive catheter method in both pulse amplitude and contour. The waveforms display agreement with minimal distortion.
Directly recorded values of cSBP and values estimated using invasive calibration method showed a strong correlation (Pearson's r ¼ 0.99, P ¼ <0.0001) with no statistically significant differences between absolute values, and a strong agreement between direct measurements and estimated values is also observed (Table 2; Fig. 2 ). The coefficient of variation was 0.03, signifying small dispersion of the estimated cSBP values relative to the recorded values. When heart rate is divided into tertiles of less than 57, 57-74 and 75 beats per minute or greater, the differences in SBP between the tertiles were similar and not statistically significant (Table 2) . Agreement between the directly measured SBP and the estimated value using invasive calibration was similar for individuals with a heart rate above and below the median. Table 3 displays the mean values and SDs of cSBP and cDBP, recorded by catheter and those estimated by Pulsecor R6.5 using a noninvasive calibration method. The 
Values are mean AE SD or numbers (%). ACE, angiotensin-converting enzyme; CAD, coronary artery disease; HMG Co-A, 3-hydroxy-3-methyl-glutaryl-CoA; PCI, percutaneous coronary intervention.
differences between absolute values observed were not statistically significant. There is a strong correlation between directly recorded cSBP and cDBP and the values estimated by Pulsecor using noninvasive calibration (Pearson's r ¼ 0.95, P < 0.0001 and 0.81, P < 0.0001, respectively) and a strong agreement between direct measurements and estimated values is also seen (Figs 3 and 4) . Again, the coefficient of variation for cSBP and cDBP were 0.05 and 0.07, respectively, signifying small dispersion relative to the corresponding recorded central pressure values. When noninvasively calibrated cSBP and cDBP estimates are plotted according to the ANSI/AAMI SP10 criteria using the fifth to 95th percentile of invasive recorded values as the range, accuracy of the readings can be observed to fall well within the SP10-recommended standard (Fig. 5) .
When cSBP recorded by catheter were compared to the corresponding brachial oscillometric readings obtained by Pulsecor, a systematic error was observed, particularly at the higher end of pressure readings (Fig. 6) . A larger coefficient of variation of 0.11 indicates a greater dispersion of brachial pressure readings relative to the corresponding invasive central pressure readings. A similar observation may be noted when comparing cDBP recorded by catheter to brachial oscillometric readings.
DISCUSSION
The cSBP and pulse pressure both predict future cardiovascular events independently of blood pressure measured at the brachial artery [23] . However, the difference between central and brachial pressure predominantly relates to differences in SBP, whereas central and peripheral diastolic pressures are similar [6] . The accuracy of the Pulsecor device for estimating central systolic pressure was the primary outcome measure in this study.
To measure central pressures in large populations, an accurate and noninvasive device that is easy to operate is needed. In this study, we demonstrated that central pressure waveforms derived by the Pulsecor R6.5 device correlated closely with those obtained invasively from a catheter. We have shown that the contour and changes in the estimated aortic waveform were similar to the invasively measured aortic pulse and the technique provided clinically acceptable estimates of central systolic pressures in patients with different age, sex, height, heart rate and disease state. In addition to the benefits of being noninvasive, Pulsecor R6.5 is much less operator dependent than applanation tonometry and the results are likely to be more consistent. The physics-based model used by Pulsecor theoretically presents some advantages over radial tonometry as a basis for generalized transfer functions: the measurement site is more proximal, resulting in less variance in arterial geometry (and avoiding the radial-ulnar bifurcation); the cuff occlusion removes effects from the downstream circulation and provides a standardized end-impedance; and it becomes hypothetically possible to tailor the model parameters to an individual participant, rather than a potentially unrepresentative sample of the population. However, such tailoring has not been applied in this study and its potential impact on accuracy is a subject of future work.
We reported results derived using both invasive and entirely noninvasive methods of calibration. In previous studies when noninvasive waveforms were calibrated using invasive diastolic and mean pressures, estimation of central systolic pressures had good agreement with the invasive measurements [18, 19, 24] . This method of calibration removes the confounding influence of the less accurate brachial cuff recordings [25] . However, invasive calibration is not possible when only noninvasive measurements are made. In this situation, the diastolic and mean pressures used to calibrate the waveform come from a noninvasive blood pressure measurement system and scaling relies on a sufficiently accurate difference between mean and diastolic pressures and the absence of any unknown systematic bias in the oscillometric measurement system. For example, it is not required by the oscillometric method that a peripheral artery waveform scaled between reported systolic and diastolic pressures will have the same mean (by integration) pressure as the mean pressure reported by oscillometry. Possibly for reasons such as these, when the noninvasive waveforms were calibrated using oscillometric brachial blood pressures, more substantial discrepancies between central pressure estimates and invasive measurements are usually reported [26] [27] [28] . In our study, the noninvasive calibration method compensated for specific and known characteristics of the proprietary oscillometric algorithm integrated into the measurement system using information available in the normalized suprasystolic waveform. Our study showed that although a larger range of differences were observed using noninvasive over invasive calibration, the agreement between invasive cSBP and those derived from oscillometric pressures using Pulsecor R6.5 device remains well within the AAMI SP10 recommendations [29] .
The ANSI/AAMI SP10 standard establishes safety and performance requirements for all sphygmomanometers which use an occluding cuff for the indirect determination of arterial blood pressure. Typically, the standard is used to compare accuracy of peripheral blood pressures from oscillometric devices with measurement by auscultation. However, the standard also includes recommendations for accuracy when compared to invasive reference pressures. SP10 Annex C: Verification of overall system efficacy by comparison with intra-arterial measurements suggests comparing the output of the device under test to the highest and lowest intra-arterial pressures during the time period the noninvasive device is measuring. This recommendation is applicable to most oscillometric blood pressure devices, which determine mean, systolic and diastolic pressures using the shape of the oscillometric envelope acquired over the entire period of the measurement. The measurement is, therefore, sensitive to fluctuations in intra-arterial blood pressure, such as those caused by natural respiratory pressure fluctuations. In this study, we applied a reference range between the fifth to 95 th percentiles to reduce oversensitivity from transient haemodynamic changes.
The AAMI SP10 criteria specify that agreement should not exceed a mean difference of 5 mmHg with a SD of the difference of 8 mmHg in an appropriately large number of measurements (25 or more for invasive comparisons). Using both invasive and noninvasive calibration methods, estimates of cSBPs by Pulsecor R6.5 were well within this range. Although the mean difference for noninvasive calibration (0.25 mmHg) has been found in this study to be closer to invasive values than the mean difference for invasive calibration (2.78 mmHg), the limits of agreement using noninvasive calibration are 60% wider, as would be expected due to the added variability introduced by the noninvasive diastolic pressures. A calculation of the 95% confidence intervals on the mean difference for the two methods shows that they overlap. The Bland-Altman plots and the correlation plots drawn have also demonstrated strong agreement and correlation between invasive and Results are also given by heart rate divided into tertiles.
Evaluation of a novel sphygmomanometer noninvasive values. Even when compared to median invasive pressures, the accuracy of noninvasive estimates was still within the AAMI SP10 standard. This finding is in contrast to previous validation studies of SphymoCor system which underestimated cSBP by 1.5-13.3 mmHg and overestimated cDBP by 10.4-12.2 mmHg [27, 28, 30] .
Study limitations
The values of estimated central systolic pressures depend on the validity and applicability of the physics-based model of the left subclavian-to-brachial branch used to generate the central aortic waveforms. This study was relatively small. Data from a larger and more varied patient population is needed to provide a more comprehensive evaluation of the reliability and accuracy of this device in a broader range of clinical settings. Fluid-filled manometer tubing was used for the invasive measurement of intraarterial pressure. Measurement error due to damping was minimized by adjusting the catheter position before invasive recordings were taken. Although fluid-filled manometer tubing may introduce high-frequency distortion to the pressure signals, it is generally agreed that central blood pressures are not dependent on these higher frequency components [31] . Also, we did not screen patients for the presence of proximal upper extremity obstructive atherosclerosis and cannot exclude this as a possible confounding variable. A potential weakness of this technology is that the calibration of central aortic pressures depends on the accuracy of the brachial pressure measurements. Tailoring of the model to an individual has not been applied in this study, and its potential impact on accuracy is a subject of future work.
In conclusion, Pulsecor R6.5 is an easy to use, sphygmomanometer-based device which can also accurately 
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Reviewers' Summary Evaluations
Reviewer 1
There is increasing interest in extending noninvasive estimation of central aortic pressure using tonometric techniques from peripheral pulse wave detection to brachial cuff-based detection of the pulse wave. This paper describes the use of a conventional brachial cuff for measurement of arterial pressure using suprasystolic cuff pulse wave to estimate central aortic pressure. This technique gives reproducible results when compared to invasive catheter recordings. Although the algorithm estimates the waveform, this study reports only values of systolic and diastolic pressure with no indices based on waveform features. There is also a systematic error increasing with pressure, but in general measurements are within accepted limits.
Reviewer 2
The study of Lin et al. evaluates Pulsecor, a novel device for noninvasive estimation of central pressures. The strength of this study is that the noninvasive Pulsecorderived central systolic pressure is validated with the directly (invasively) measured aortic systolic pressure, confirming a satisfactory agreement between these measurements. The findings of the study have potential clinical implications, as accumulating evidence suggests that central pressures are predictors of cardiovascular outcomes. However, in the light of recent data showing a superiority of the clinical relevance of central pulse pressure compared to central systolic pressure, the performance of Pulsecor in estimating central pulse pressure needs to be evaluated.
